Results 1 to 10 of about 14,642 (226)

Complications of corneal collagen cross-linking [PDF]

open access: yesIndian Journal of Ophthalmology, 2022
Corneal collagen cross-linking (CXL) is an effective treatment for arresting progression in patients with keratoconus. CXL was approved by United States Food and Drug Administration for the treatment of progressive keratoconus in 2016. It is a relatively
Richa Agarwal, Parul Jain, Ritu Arora
doaj   +4 more sources

Corneal collagen cross-linking: A review

open access: yesJournal of Optometry, 2014
The aim was to review the published literature on corneal collagen cross-linking. The emphasis was on the seminal publications, systemic reviews, meta-analyses and randomized controlled trials. Where such an evidence did not exist, selective large series
David P.S. O’Brart
doaj   +5 more sources

Scheimpflug imaged corneal changes on anterior and posterior surfaces after collagen cross-linking [PDF]

open access: yesInternational Journal of Ophthalmology, 2014
AIM: To compare the anterior and posterior corneal parameters before and after collagen cross-linking therapy for keratoconus.METHODS: Collagen cross-linking was performed in 31 eyes of 31 keratoconus patients (mean age 30.6±8.9y). Prior to treatment and
Ziad Hassan   +4 more
doaj   +4 more sources

Complications of Corneal Collagen Cross-Linking [PDF]

open access: yesJournal of Ophthalmology, 2011
Cross-linking of corneal collagen (CXL) is a promising approach for the treatment of keratoconus and secondary ectasia. Several long-term and short-term complications of CXL have been studied and documented. The possibility of a secondary infection after
Shikha Dhawan   +2 more
doaj   +4 more sources

Corneal collagen cross-linking for treating keratoconus. [PDF]

open access: yesCochrane Database of Systematic Reviews, 2015
BACKGROUND: Keratoconus is a condition of the eye that affects approximately 1 in 2000 people. The disease leads to a gradual increase in corneal curvature and decrease in visual acuity with consequent impact on quality of life.
Amissah-Arthur, Kwesi N   +7 more
core   +4 more sources

Rapid keratitis and perforation after corneal collagen cross-linking [PDF]

open access: yesAmerican Journal of Ophthalmology Case Reports, 2020
Purpose: To describe a case of rapid keratitis and corneal perforation after epithelium off collagen cross-linking. Observations: We report a case of a 17-year-old male who underwent collagen cross-linking with the protocol and device approved by the ...
Matthew Schear   +4 more
doaj   +2 more sources

Updates on corneal collagen cross-linking: Indications, techniques and clinical outcomes

open access: yesJournal of Current Ophthalmology, 2017
Purpose: To review the historical background and basic principles of collagen cross-linking, to bring together the data regarding the outcomes and complications of collagen cross-linking and finally to explore the efficacy and safety of new variations of
Mehrdad Mohammadpour   +4 more
doaj   +3 more sources

Keratoconus and corneal collagen cross-linking

open access: yesIndian Journal of Ophthalmology, 2013
Keratoconus, a degenerative disorder of the cornea, causes significant visual distortion and photophobia. Diagnosed in early life, it has a considerable influence on the patient's daily activities and visual needs. A study of the rural population in Central India gave a prevalence of 2.3% +/- 0.2% among those aged 30 years and above.[1] The ...
Rohit Shetty
doaj   +3 more sources

Evolution of Corneal Collagen Cross-linking

open access: yesDelhi Journal of Ophthalmology, 2023
Corneal Collagen crosslinking (CXL) has brought a breakthrough in the field of ophthalmology. CXL strengthens the corneal tissue by utilizing riboflavin (Vitamin B2) which acts as a photosensitizer. CXL has been evolving over many years.
Gunjan Budhiraja
doaj   +2 more sources

Clinical outcomes at one year following keratoconus treatment with accelerated transepithelial cross-linking [PDF]

open access: yesInternational Journal of Ophthalmology, 2017
This study evaluated the clinical outcomes in keratoconus corneas following accelerated transepithelial corneal collagen cross-linking (CXL) (Avedro KXL® system, Waltham, MA, USA) over one year of follow-up.
Alberto Artola   +4 more
doaj   +5 more sources

Home - About - Disclaimer - Privacy